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SIGMAR1 mutation associated with
autosomal recessive Silver-like syndrome
ABSTRACT
Objective: To describe the genetic and clinical features of a simplex patient with distal hereditary
motor neuropathy (dHMN) and lower limb spasticity (Silver-like syndrome) due to a mutation in the
sigma nonopioid intracellular receptor–1 gene (SIGMAR1) and review the phenotypic spectrum of
mutations in this gene.
Methods: We used whole-exome sequencing to investigate the proband. The variants of interest
were investigated for segregation in the family using Sanger sequencing. Subsequently, a larger
cohort of 16 unrelated dHMN patients was specifically screened for SIGMAR1 mutations.
Results: In the proband, we identified a homozygous missense variant (c.194T.A, p.Leu65Gln) in
exon 2 of SIGMAR1 as the probable causative mutation. Pathogenicity is supported by evolu-
tionary conservation, in silico analyses, and the strong phenotypic similarities with previously
reported cases carrying coding sequence mutations in SIGMAR1. No other mutations were iden-
tified in 16 additional patients with dHMN.
Conclusions: We suggest that coding sequence mutations in SIGMAR1 present clinically with
a combination of dHMN and pyramidal tract signs, with or without spasticity, in the lower
limbs. Preferential involvement of extensor muscles of the upper limbs may be a distinctive
feature of the disease. These observations should be confirmed in future studies. Neurology®
2016;87:1607–1612
GLOSSARY
ALS 5 amyotrophic lateral sclerosis; CMT 5 Charcot-Marie-Tooth disease; dHMN 5 distal hereditary motor neuropathy;
dHMN-J 5 distal hereditary motor neuropathy and pyramidal features identified in the Jerash region of Jordan; ER 5
endoplasmic reticulum; ExAC 5 Exome Aggregation Consortium database; HSP 5 hereditary spastic paraplegia; MAF 5
minor allele frequency; MRC 5 Medical Research Council; s1R 5 sigma-1 receptor; SIGMAR1 5 sigma nonopioid intracel-
lular receptor–1 gene; UTR 5 untranslated region; WES 5 whole-exome sequencing.
The distal hereditary motor neuropathies (dHMN) comprise a heterogeneous group of diseases
that share the common feature of slowly progressive, symmetrical, and distal-predominant neu-
rogenic weakness and amyotrophy.1 There is phenotypic and genetic overlap between dHMN
and other hereditary neuropathies and motor neuron disorders such as axonal forms of Charcot-
Marie-Tooth disease (CMT2), juvenile amyotrophic lateral sclerosis (ALS), and hereditary
spastic paraplegia (HSP). BSCL2- and REEP1-related disorders are an example of this overlap
as autosomal dominant mutations in these genes can cause dHMN with upper limb predom-
inance, pure HSP, or spastic paraplegia with amyotrophy of hands (Silver syndrome) or hands
and feet (table 1).2–6
Homozygous mutations in the sigma nonopioid intracellular receptor-1 gene (SIGMAR1)
have been reported as a cause of dHMN and juvenile ALS.7,8 Here we describe a patient with
a Silver-like syndrome carrying a homozygous mutation in SIGMAR1 and review the
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phenotypic spectrum of mutations in this
gene. We suggest that coding sequence muta-
tions present clinically with a combination of
dHMN and pyramidal tract signs, with or
without spasticity, in the lower limbs, adding
SIGMAR1 to the list of genes that can cause
overlapping motor neuron/nerve phenotypes.
METHODS The proband and 16 additional patients screened
for SIGMAR1 mutations were identified from those attending
neuropathy clinics at the National Hospital for Neurology and
Neurosurgery, Queen Square, London, UK. The proband was
investigated as part of a larger study to determine the genetic
etiology in patients with inherited neuropathies using whole-
exome sequencing (WES). All patients had undergone clinical
and instrumental assessments during the routine diagnostic
process and mutations in common neuropathy-related genes
had been excluded in all cases. Nerve conduction studies,
EMG, laboratory tests, and MRI scans were performed using
standard methods. WES, Sanger sequencing, and in silico
analysis methods are detailed in the supplementary material at
Neurology.org.
Standard protocol approvals, registration, and patient
consents. The study had ethical approval from the National
Hospital for Neurology & Neurosurgery/Institute of Neurology
Joint Research Ethics Committee. All patients gave written
informed consent for genetic testing.
RESULTS Clinical features. The proband (figure, A)
was the second child of healthy, nonconsanguineous
parents of British and French descent. He walked
independently at age 12 months. At age 3 years, he
was noted to have bilateral foot drop and frequent
falls and, over the following years, he developed pro-
gressive muscle weakness and atrophy in the lower
limbs. Hand weakness and lower limb stiffness
developed during the second decade of life. He
underwent orthopedic surgery on his feet at ages
13–14 years and tendon-transfer surgery on both
thumbs at ages 16–17 years with good functional
outcomes. He has normal intellect, no sensory
symptoms, and no sphincter problems. His family
history was unremarkable and clinical and
electrophysiologic examination of the parents was
normal.
At age 17 years, on neurologic examination, he had
clawed hands with no fixed contractures, bilateral fin-
ger and foot drop, knee bobbing, marked muscle atro-
phy from mid-forearms and knees down (figure, B),
and weakness of wrist extension (Medical Research
Council [MRC] grade 2/5 right, 4/5 left), finger
extension (1/5), intrinsic hand muscles (0/5), ankle
dorsiflexion (0/5 right, 1/5 left), ankle plantar flexion
(1/5), toe extension (1/5), and toe flexion (0/5).
Muscle strength in proximal muscles and finger flexors
was normal. There was marked spasticity of the lower
limbs and normal muscle tone in the upper limbs.
Deep tendon reflexes were present in the upper limbs,
increased at the knees, and absent at the ankles. Ba-
binski sign was present bilaterally. Sensory and cranial
nerve examinations were unremarkable. He walked
with a combination of spastic and steppage gait. There
was no scoliosis. Nerve conduction studies were con-
sistent with a motor axonal neuropathy that was more
severe in the lower limbs (table e-1). The superficial
peroneal sensory action potential was normal and
although the sural sensory nerve action potential
amplitude was mildly reduced this may have been
due to previous surgery rather than a sensory neu-
ropathy. EMG of the biceps brachii showed features
of chronic denervation. Brain and spinal cord MRIs
were normal. Charcot-Marie-Tooth Neuropathy
Score v.2 was 13.9
At age 20, neurologic examination confirmed pro-
gression of wrist extension weakness (MRC grade
1/5) causing hand drop and weakness of finger flexion
(4/5) (video). The remainder of the examination was
unchanged. MRI of the lower limbs demonstrated
normal appearance of the thigh muscles and atrophy
of all lower leg muscles with mild fatty replacement
(figure, C). Serum creatine kinase level was normal
at 184 IU/L.
Genetic studies. Molecular genetic analysis of the
17p11.2 chromosome region and direct sequencing
of MFN2, HSPB1, HSPB8, HSPB3, BSCL2, and
GARS genes revealed no pathogenic variants. WES
on the proband revealed a total of 25,073 exonic
variants (table e-2). The GEM.app software was used
to focus on nonsynonymous, splice-site, and coding
indel variants that were present in ,5 families in the
GEM.app database and that had a minor allele
Table 1 Genes and loci identified in distal hereditary motor neuropathies
(dHMN) with upper motor neuron signs or with Silver syndrome
Gene/locus Inheritance Alternative name MIM number
dHMN with upper motor neuron signs
SETX AD ALS4 602433
BSCL2 AD dHMN5 600794
GARS AD dHMN5 600794
4q34.3–q35.2 AD HMSN5 600361
9p21.1–p12 AR dHMN Jerash type 605726
Silver syndrome
BSCL2 AD SPG17 270685
REEP1 AD SPG31 610250
SPAST AD SPG4 182601
4p16–p15 AD SPG38 612335
AD 5 autosomal dominant; ALS 5 amyotrophic lateral sclerosis; AR 5 autosomal recessive;
dHMN5 5 distal hereditary motor neuropathy with upper limb predominance; HMSN 5 hered-
itary motor and sensory neuropathy; MIM number 5 catalogue assignment for the disease in
the Mendelian Inheritance in Man system (omim.org/); SPG 5 spastic paraplegia.
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frequency (MAF) ,0.5% in the Exome Variant
Server database (http://evs.gs.washington.edu/EVS/).
From a total of 198 variants that met these filtering
criteria, 9 of them involved genes associated with pure
and complex inherited neuropathies/neuronopathies.
Six were heterozygous variants in genes associated with
autosomal recessive disorders (ERCC6, LAMA2,
MTPAP, MTTP, NTRK1, and PRX). Two
heterozygous variants were detected in genes
associated with autosomal dominant spinal muscular
atrophy and CMT2 (BICD2 and TRPV4) and one
homozygous variant was detected in SIGMAR1,
a gene associated with autosomal recessive dHMN
and juvenile ALS. The variants detected in BICD2,
TRPV4, and SIGMAR1 were validated by direct
sequencing.
Cosegregation analyses allowed exclusion of
the BICD2 and TRPV4 variants as pathogenic
(e-Results) and confirmed that the proband’s
parents were heterozygous carriers of the SIGMAR1
variant c.194T.A located in exon 2 (Ensembl ID
ENST00000277010) (figure, D). This variant was
present in 4 out of 97,910 alleles (MAF 0.004%)
in the Exome Aggregation Consortium database
(ExAC http://exac.broadinstitute.org/), with none
of the carriers being homozygous, and was absent
in the GEM.app database and in an in-house exome
database of 138 clinically and neuropathologically
normal controls. c.194T.A leads to the substitu-
tion of nonpolar leucine for polar glutamine at
amino acid position 65 (p.Leu65Gln), affects
a highly conserved nucleotide and amino acid
(figure, E), and is predicted as being deleterious or
disease-causing by pathogenicity prediction tools
(table e-3).
The 4 coding exons, intron/exon boundaries, and
the 39-untranslated region (39-UTR) of SIGMAR1
were Sanger sequenced in the proband and 16 addi-
tional unrelated dHMN patients. No other exonic or
intronic changes were identified (table e-4).
DISCUSSION Using WES in a simplex patient with
distal weakness and amyotrophy and lower limb spas-
ticity and electrophysiologic features consistent with
Figure Family segregation, conservation of the SIGMAR1 variant, and clinical images of the proband
(A) Segregation of the SIGMAR1 variant c.194T.A in the family; genotypes are indicated below tested individuals. (B) Photographs of the proband show
atrophy of intrinsic hand muscles, clawed hands, flexed knee posture (characteristic of knee bobbing), and atrophy of leg and foot muscles. (C) Axial T1-
weighted MRI of the mid-thighs (left) and mid-legs (right) demonstrate normal appearance of the thigh muscles and atrophy of all lower leg muscles with mild
fatty replacement especially of tibialis anterior, tibialis posterior, soleus, and peroneal muscles. (D) Sanger sequencing electropherograms demonstrate
sequence variants in the proband and his parents. (E) Conservation of leucine (L) at amino acid position 65 of the s-1 receptor encoded by SIGMAR1;
a subset of 16 species were chosen, representing the 100 species available at the USCS browser.
Neurology 87 October 11, 2016 1609
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
a motor neuropathy, we have identified SIGMAR1 as
the probable causative gene. The phenotype of the
patient mimics classical Silver syndrome except for
the absence of upper limb predominance and the
autosomal recessive pattern of inheritance; we termed
this novel phenotype Silver-like syndrome.
Pathogenicity of the SIGMAR1 variant is supported
by the in silico analysis described above and previous
reports of individuals carrying homozygous mutations
in the same gene, which are summarized in table 2.7,8
Like the present case, affected individuals from
previously reported families developed a combination
of distal weakness in the upper 6 lower limbs and
pyramidal features in the lower limbs. Both our case
and those with the mutation c.304G.C, located in
exon 2, presented within the first 3 years of life and
had severe involvement of forearm extensors and
lower limb spasticity.7 Although the authors desig-
nated the cases with c.304G.C as juvenile ALS, they
had no bulbar involvement and EMG evidence of
Table 2 Genetic and clinical features of patients with SIGMAR1 mutations
Present study, 2016 Li et al., 20158 Al-Saif et al., 20117
No. cases/kindred 1/1 3/1 6/1
Ethnicity French–British Chinese Saudi Arabian
Type of mutation Homozygous, missense Homozygous, splice-site Homozygous, missense
Exon/intron Exon 2 Intron 1 Exon 2
cDNA change c.194T.A c.15111G.T c.304G.C
Protein change p.Leu65Gln p.Gly31_Ala50dela p.Glu102Gln
Protein domain14 Cytoplasmic Cytoplasmic Transmembrane
Disease onset, y 3 9–12 1–2
Motor delay No No NA
Initial symptoms Foot drop, frequent falls Foot drop, pes varus Lower limb spasticity and
weakness
Hand involvement, y 12–13 11–15 9–10
Upper limb weakness Yes; finger and wrist
extensors . flexors
Yes; difficulty to straighten fingers
at age 13 in one patient
Yes; paralysis of forearm
extensors and triceps
Lower limb weakness Yes Yes Yes
Distal predominant
wasting/weakness
Yes Yes Upper limbs
Clinical fasciculations No No NA
Upper limb spasticity No No NA
Lower limb spasticity Yes No Yes
Upper limb DTRs Normal NA NA
Knee DTRs Increased Increased Increasedb
Ankle DTRs Absent Absent Increasedb
Babinski sign Yes Yes NA
Sensory deficit No No No
Bulbar involvement No No No
Respiratory involvement No No No
Cognitive impairment No No No
Brain MRI Normal Normal Normal
Spinal cord MRI Normal Normal NA
Creatine kinase Normal Normal NA
Phenotype description dHMN with UMN signs/
spasticity in lower limbs
dHMN with UMN signs in lower limbs ALS; UMN signs/spasticity in
lower limbs
Abbreviations: ALS 5 amyotrophic lateral sclerosis; dHMN 5 distal hereditary motor neuropathy; DTRs 5 deep tendon
reflexes; SIGMAR1 5 sigma nonopioid intracellular receptor–1 gene; UMN 5 upper motor neuron.
Esembl reference sequences for SIGMAR1: ENSG00000147955; ENST00000277010.
a c.15111G.T causes an alternative splicing event that generates an in-frame deletion of 60 bp in exon 1 (c.92_151del,
p. Gly31_Ala50del).
b Reported originally as lower limb spasticity and weakness accompanied by exaggerated tendon reflexes.
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active denervation is not mentioned in the report.
Thus, it appears that all these patients with exon 2
mutations share the same phenotype.
The cases with dHMN due to the splice-site
mutation c.15111G.T, resulting in deletion of
the last 20 amino acids encoded by exon 1, had a later
age at onset and lacked spasticity.8 As suggested by
the authors, this phenotype is similar to that
described in patients with dHMN and pyramidal fea-
tures identified in the Jerash region of Jordan
(dHMN-J) and mapped to 9p21.1-p12, which en-
compasses SIGMAR1.10 It is also significant that, as
observed in our patient and those with the mutation
c.304G.C, patients with dHMN-J had preferential
involvement of forearm extensors over flexors.
The homozygous variant rs4879809
(9:34635598T.C, c.*31A.G), located in the 39-
UTR of SIGMAR1, has been detected in a consan-
guineous family with adult-onset ALS.11 The authors
suggested that c.*31A.G could contribute to the
pathogenesis of ALS in this family. The allele C in
9:34635598, however, has a frequency of 99.5% in
the ExAC database (99% homozygotes) and was pres-
ent in all patients from our cohort and the proband’s
unaffected parents so we regarded it as nonpatho-
genic. Heterozygous 39-UTR variants in SIGMAR1
have been also identified in individuals with fronto-
temporal lobar degeneration–motor neuron disease
but their pathogenic role is still unclear.12,13
SIGMAR1 encodes for the sigma-1 receptor (s1R),
an endoplasmic reticulum (ER) chaperone that resides
at the specialized mitochondrial-associated ER mem-
brane.14 s1R is involved in a wide array of cellular
processes, including ER-mitochondrial Ca21 signaling
and cell survival, and is highly expressed in motor
neurons of the brainstem and spinal cord.14,15 Recent
studies suggest that loss of s1R function causes ER–
mitochondria disconnection and ER stress activation
and disrupts mitochondrial function and axonal trans-
port, leading to motor neuron axonal degeneration
followed by cell death.16 This dying-back degeneration
process would be consistent with the distal predomi-
nant pattern of motor involvement seen in patients
with SIGMAR1 mutations.
Based on the present study and previous reports,
we propose that coding sequence mutations in
SIGMAR1 manifest clinically with a combination of
dHMN and pyramidal tract signs, with or without
spasticity, in the lower limbs, and that preferential
involvement of forearm extensors may be a distinctive
feature of the disease. These observations should be
confirmed in future studies.
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